How Moderna's Second Worst Nightmare Could Become a Reality

Moderna (NASDAQ:MRNA) is living the dream that most biotechs aspire to achieve. In late 2018, the company pulled off what was at the time the biggest initial public offering (IPO) in biotech history. Its messenger RNA technology captured the imaginations -- and pocketbooks -- of investors.